FirmaIQ
Org.nr 991 729 666 2024 → 2025 Year-over-year analysis

ABBOTT MEDICAL NORWAY AS: årsregnskap 2025 vs 2024

Grew 8% on revenue

approved 2026-06-23; registry 2026-08-01; journal 2026 664335

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2025 with 2024 for ABBOTT MEDICAL NORWAY AS. Revenue 188.54m NOK → 202.78m NOK (+7.6%). Net result +5.03m NOK → +5.81m NOK. Equity 34.19m NOK → 40.00m NOK.

On the constructive side: revenue rose; operating result improved; net result improved.

Also worth watching: paid-in equity reduced. All figures are taken from the published annual accounts for ABBOTT MEDICAL NORWAY AS.

At a glance

Scorecard

Revenue
188.54m NOK 202.78m NOK
+7.6%
Operating result
+5.67m NOK +6.45m NOK
+13.7%
Net result
+5.03m NOK +5.81m NOK
+15.5%
Equity
34.19m NOK 40.00m NOK
+17.0%
Cash
14.66m NOK 19.42m NOK
+32.5%
Total assets
74.20m NOK 78.66m NOK
+6.0%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 188.54m NOK to 202.78m NOK (+7.6% YoY). Calculated

  • ↑

    Operating result improved

    Operating result +5.67m NOK → +6.45m NOK (op. margin 3.0% → 3.2%). Calculated

  • ↑

    Net result improved

    Net result +5.03m NOK → +5.81m NOK (net margin 2.7% → 2.9%). Calculated

  • ↑

    Equity strengthened

    Book equity 34.19m NOK → 40.00m NOK (equity ratio 46.1% → 50.9%). Calculated

  • ↑

    Cash rose

    Bank deposits 14.66m NOK → 19.42m NOK (+32.5% YoY). Calculated

Things to notice

  • ·

    Paid-in equity reduced

    Paid-in equity fell 200.0k NOK → 10 NOK — check capital reduction, conversion, or reclassification. Interpretation